Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19

NEXT STORY
Survey: Still Not Enough Americans Willing to Take COVID-19 Vaccines to Achieve Herd Immunity
PREV STORY
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiasma Provides Corporate Update and Previews Expected 2021 Milestones

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Closing of $20 Million Underwritten Offering

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News

Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News